Allergy Immunotherapy Market to Reach USD 8.7 Billion by 2036 as Disease-Modifying Treatments Reshape Allergy Care

The global Allergy Immunotherapy Market is entering a high-growth phase as healthcare systems increasingly move beyond temporary symptom relief toward therapies designed to modify the underlying allergic response. The market was valued at USD 3.2 billion in 2025 and is projected to reach USD 8.7 billion by 2036, expanding at a 10.5% CAGR from 2026 to 2036.

👉 Get sample market research report copy now@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=35708

Allergen immunotherapy works by exposing patients to controlled amounts of specific allergens to gradually reduce immune sensitivity. Major applications include allergic rhinitis, allergic asthma, food allergy, and insect venom allergy. Subcutaneous immunotherapy (SCIT), sublingual immunotherapy (SLIT), and emerging oral approaches are expanding treatment choices and improving the long-term management of allergic diseases.

Market Overview

Market growth is being supported by the increasing global burden of allergies, greater diagnosis and awareness, improving healthcare infrastructure, and growing acceptance of disease-modifying therapies. Unlike antihistamines, decongestants, and other symptomatic medicines that primarily control symptoms, immunotherapy aims to influence the immune response to allergens.

The market reached USD 3.2 billion in 2025 and is forecast to more than double by 2036. SCIT accounted for approximately 63% of the market by treatment in 2025, while Europe held the leading regional share at around 35%.

Growing investments in allergen standardization, formulation technologies, clinical research, and specialized allergy clinics are further strengthening the market's commercial potential.

Key Drivers of Market Growth

Rising Prevalence of Allergic Conditions

The increasing incidence of allergic rhinitis, asthma, food allergies, eczema, and venom allergies remains the primary market driver. Urbanization, pollution, changing lifestyles, environmental exposure, and climate-related changes are contributing to greater allergy concerns worldwide.

According to CDC data reported in January 2026, 25.2% of U.S. adults experienced seasonal allergies in 2024, while 6.7% experienced food allergies. Among children, seasonal allergies affected 20.6% and food allergies affected 5.3%.

As recurring and severe allergies create a greater need for long-term disease management, physicians and patients are increasingly considering allergen-specific immunotherapy.

Regulatory Support

Clearer regulatory pathways are supporting innovation and investment. The European Medicines Agency's guideline for allergen products used in immunotherapy and allergy diagnostics came into legal effect on January 1, 2026. The framework provides greater clarity around clinical development and assessment of allergen products.

More predictable regulatory requirements can encourage manufacturers to invest in new formulations, standardized allergen extracts, and targeted therapies while strengthening confidence among healthcare providers and patients.

Key Players and Industry Leaders

Leading companies include ALK-Abelló A/S, Stallergenes Greer, Allergy Therapeutics plc, HAL Allergy Group, DBV Technologies, Allergopharma GmbH & Co. KG, Inmunotek S.L., LETI Pharma S.L.U., Torii Pharmaceutical Co., Ltd., HollisterStier Allergy, Jubilant Pharmova Limited, and Laboratorios Diater S.A.

Key Trends for the Future

The market is shifting toward more convenient, standardized, and patient-focused immunotherapy. SLIT and oral approaches are attracting attention because they can offer alternatives to repeated injections for selected patients.

Personalized treatment is another important direction. Manufacturers are investing in allergen-specific formulations designed around different patient profiles and allergy types.

Digital patient education, monitoring systems, improved dosing protocols, and specialized allergy clinics are also expected to support treatment adherence. At the same time, research into polymerized allergens and allergoids is aimed at balancing efficacy with improved safety.

Explore our report to uncover in-depth insights - https://www.transparencymarketresearch.com/allergy-immunotherapy-market.html

New Opportunities and Challenges

Expansion of regulated oral and sublingual immunotherapy products represents a major opportunity. Food allergy management, in particular, could become an important growth area as healthcare providers seek controlled, evidence-based approaches.

The growing establishment of allergy clinics across emerging economies also creates opportunities for manufacturers to expand distribution and clinical access.

However, challenges remain. Immunotherapy can require lengthy treatment periods, clinical supervision, patient adherence, and careful risk management. Product development can also be complex because allergen preparations are biologically sourced and often require detailed clinical and regulatory evaluation. Cost, reimbursement differences, and limited specialist availability may restrict adoption in some markets.

Market Trends & Innovations

Innovation is increasingly centered on improving allergen formulations and treatment delivery. Research into cross-linked and polymerized allergen extracts aims to reduce IgE reactivity while maintaining immunogenic capacity.

Manufacturers are also expanding SCIT and SLIT portfolios while exploring oral immunotherapy solutions. Better allergen standardization can improve consistency between products and potentially strengthen physician confidence.

The industry is additionally moving toward broader disease-specific applications, particularly respiratory allergies, food allergies, and venom hypersensitivity.

Future Outlook

The Allergy Immunotherapy Market is expected to maintain strong growth through 2036 as allergy prevalence rises and healthcare systems recognize the economic and clinical burden of untreated or recurring allergic disease.

Europe is expected to remain a major market, supported by established allergy-care networks, reimbursement structures, clinical expertise, and strong industry participation. North America should also offer significant opportunities, while Asia-Pacific could become increasingly attractive because of improving healthcare infrastructure, rising awareness, and a large patient population.

The next phase of market development will likely be shaped by regulatory clarity, innovative formulations, personalized treatment strategies, and greater adoption of convenient delivery methods.

Market Segmentation

The Allergy Immunotherapy Market is segmented by:

By Treatment

• Subcutaneous Immunotherapy (SCIT)
• Sublingual Immunotherapy (SLIT)

By Allergy Type

• Allergic Rhinitis
• Asthma
• Food Allergy
• Venom Allergy
• Others

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies & Drug Stores
• Online Pharmacies

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa

👉 To buy this comprehensive market research report, click here to inquire@ https://www.transparencymarketresearch.com/checkout.php?rep_id=35708<ype=S

Important FAQs with Answers

What is the size of the Allergy Immunotherapy Market in 2025?

The global market was valued at approximately USD 3.2 billion in 2025.

What will the Allergy Immunotherapy Market be worth by 2036?

The market is projected to reach approximately USD 8.7 billion by 2036.

What is the expected market CAGR?

The market is forecast to expand at a 10.5% CAGR from 2026 to 2036.

Which treatment segment leads the market?

SCIT is the leading treatment segment, accounting for approximately 63% of market value in 2025.

Which region dominates the market?

Europe led the global market in 2025, representing approximately 35% of revenue.

More Trending Reports by Transparency Market Research –

Protein Therapeutics Market: https://www.transparencymarketresearch.com/protein-therapeutics-market.html

Drug Discovery Platforms Market: https://www.transparencymarketresearch.com/drug-discovery-platforms-market.html

Next-Generation Immunotherapies Market: https://www.transparencymarketresearch.com/next-generation-immunotherapies-market.html

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Media Contact: 

Abhishek Budholiya

Transparency Market Research Inc.

State Tower, 90 State Street, Suite 700,

Albany NY - 12207, United States

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com 

Sales Inquiries: sales@transparencymarketresearch.com

Media Inquiries: media@transparencymarketresearch.com